MIKAJAKI has developed EyeLib, a fully automated station that delivers full reports including optical prescription parameters and objective diagnostics for most vision‑threatening eye conditions using ophthalmic diagnostic devices, robotics and artificial intelligence. The platform includes patient profiling to enable customized follow-up and specialist referrals. MIKAJAKI says EyeLib will reshape the clinical pipeline to make eye clinics and health institutions more efficient and to save time and money for patients, doctors, opticals, researchers, pharmaceutical suppliers and insurers. The company is based at Fongit in Geneva and has contracts with over ten large European ophthalmic centers and ophthalmic device manufacturers. It has announced a partnership with Pallas Kliniken, a network of more than 16 locations and 120 doctors that treats over 150,000 patients annually. MIKAJAKI raised new funding to accelerate regulatory work toward CE certification.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

Jun 2020